23 May 2013
Keywords: GlaxoSmithKline, Genmab, Arzerra, Shionogi, Ospemifene, Leukemia, VVA, Japan filings
Article | 02 May 2012
UK pharma giant GlaxoSmithKline (LSE: GSK) and Danish company Genmab A/S (OMX: GEN) have submitted a New Drug Application ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 May 2012
3 May 2012
22 May 2013
© 2013 thepharmaletter.com